DermaClip US, LLC introduces a revolutionary solution to wound closure with its non-invasive device that replaces traditional sutures, staples, and glues for skin closure. The patented design not only enables quick and easy closure of surface wounds but also promotes healthy healing by evertting the skin on every closure. This innovative approach aims to set a new standard in wound closure, prioritizing ease of use and patient experience. The single-use, needle-less device, equipped with a patented mechanism, ensures full eversion with each closure, making it user-friendly and beneficial for a wide range of patients.
Founded in 2015, DermaClip offers a simple training process that enables even lesser-trained staff to achieve proper wound closure. The device, made of top-quality non-latex adhesive, is designed to maintain wound closure for 7 to 10 days, catering to patient comfort and convenience. Positioned at the intersection of healthcare and medical technology, DermaClip presents a promising investment opportunity for venture capitalists seeking innovative solutions in the medical industry.